EMCURE

Emcure Pharmaceuticals Limited

Pharmaceuticals

Share price

₹1,922

Market cap

₹36,470 Cr

1Y return

▲ 34%

A global pharmaceutical manufacturer established in 1981, Emcure Pharmaceuticals produces and markets a comprehensive range of drug formulations across multiple therapeutic areas for domestic and international markets. The company operates manufacturing facilities that serve patients globally, focusing on both generic and specialty pharmaceutical products. Emcure's diversified operations and geographic presence establish it as a significant player in the pharmaceutical industry.

Recent moves 11

Moves11

Morgan StanleyNew position

Morgan Stanley bought 1,37,590 shares of Emcure Pharmaceuticals for ₹25.00 Cr at ₹1817.00 apiece in a block deal. This transaction occurred on June 25, 2026.

HSBC Mutual FundNew position

HSBC Mutual Fund bought 1,37,590 shares of Emcure Pharmaceuticals for ₹25.00 Cr at ₹1,817.00 apiece in a block deal.

HDFC Life InsuranceNew position

HDFC Life Insurance bought 5,56,954 shares of Emcure Pharmaceuticals for ₹101.20 Cr at ₹1817.00 apiece in a block deal.

Goldman SachsNew position

Goldman Sachs bought 1,37,590 shares of Emcure Pharmaceuticals Limited for ₹25.00 Cr at ₹1817.00 apiece in a block deal.

BNP ParibasNew position

BNP Paribas bought 137,592 shares of Emcure Pharmaceuticals for ₹25.00 Cr at ₹1817.00 apiece in a block deal.

Axis Mutual FundNew position

Axis Mutual Fund bought 1,37,590 shares of Emcure Pharmaceuticals for ₹25.00 Cr at ₹1817.00 apiece in a block deal.

Aditya Birla Sun Life Mutual FundNew position

Aditya Birla Sun Life Mutual Fund bought 2,61,420 shares of Emcure Pharmaceuticals for ₹47.50 Cr at ₹1817.00 apiece in a block deal.

Kotak Mutual FundNew position

Kotak Mutual Fund bought 36 lakh shares of Emcure Pharmaceuticals for ₹612 crore at ₹1700.00 apiece in a block deal.

Kotak Mutual FundNew position

Kotak Mutual Fund bought 36 lakh shares of Emcure Pharmaceuticals for ₹612.00 Cr at ₹1700.00 apiece in a bulk deal.

Government Pension Fund Global (Norway)New position

Government Pension Fund Global (Norway) bought 18,00,000 shares of Emcure Pharmaceuticals for ₹289.48 crore at ₹1608.20 apiece in a bulk deal.

Track the whales in Emcure Pharmaceuticals Limited

Get alerted the moment a top investor buys or sells.